The emerging role of anti-thymic stromal lymphopoietin monoclonal antibody (Tezepelumab) in comorbid and non-comorbid CRSwNP patients: a scoping review. This evidence concerns the gene TSLP and chronic rhinosinusitis with nasal polyps.